FDA approval for preloaded capsular tension ring
OPHTEC USA has received FDA approval for its RingJect design changes
Colin Kerr
Published: Saturday, June 1, 2019
OPHTEC USA has received FDA approval for the RingJect™ delivery system design optimisation changes.
The OPHTEC CTR is made of PMMA with patented compression moulding technology, making for
a durable, flexible device to stabilise the capsular bag in the presence of weakened or compromised zonules.
Abraham Farhan, Vice President and General Manager of OPHTEC USA, said: “We are grateful that the FDA has approved the Ophtec RingJect with optimised delivery system enhancements. Our surgeons and patients will continue to benefit from our legacy Capsular Tension Ring (CTR).
“We are very excited about the RingJect, as it saves time in surgery and reduces surgical preparation time.”
https://www.ophtec.com/
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.
AI Scribing and Telephone Management
Automating note-taking and call centres could boost practice efficiency.